Myriad Genetics Inc
XMUN:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XMUN:MYD
|
US |
|
Northwest Pipe Co
F:NW7
|
US |
|
K
|
Kennedy-Wilson Holdings Inc
F:13K
|
US |
|
T
|
Trip.com Group Ltd
NASDAQ:TCOM
|
CN |
|
Tesmec SpA
MIL:TES
|
IT |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
SB Financial Group Inc
F:9KH
|
US |
|
A
|
Ares Commercial Real Estate Corp
F:41I
|
US |
|
L
|
La-Z-Boy Inc
F:LAZ
|
US |
|
I
|
Ingredion Inc
XMUN:CNP
|
US |
|
Guotai Junan Securities Co Ltd
F:153A
|
CN |
|
GitLab Inc
F:8K2
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
F:TKDA
|
JP |
|
P
|
Petroleo Brasileiro SA Petrobras
DUS:PJXA
|
BR |
|
Establishment Labs Holdings Inc
F:3E0
|
CR |
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
|
J
|
JD.Com Inc
SWB:013A
|
CN |
|
Thomson Reuters Corp
F:TOC
|
CA |
|
T
|
Trip.com Group Ltd
F:CLV
|
CN |
|
M P Evans Group PLC
F:NYP
|
UK |
|
V
|
Visteon Corp
XMUN:VS51
|
US |
|
C
|
Coterra Energy Inc
XMUN:XCQ
|
US |
|
Deutsche EuroShop AG
F:DEQ
|
DE |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
According to Wall Street analysts, the average 1-year price target for
MYD is 5.453 EUR with a low forecast of 3.471 EUR and a high forecast of 9.022 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
5.453
EUR
According to Wall Street analysts, the average 1-year price target for
MYD is 5.453 EUR with a low forecast of 3.471 EUR and a high forecast of 9.022 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.